Why the study?
Long noncoding RNAs correlate with hepatocellular carcinoma survival, but a lncRNA signature to predict patient prognostic risk needed to be identified.
Does a four-lncRNA signature predict survival in patients with hepatocellular carcinoma?
Population
180 HCC patients from Tanric and TCGA databases
Comparison
Patients stratified by a four-lncRNA prognostic signature
Design
Statistical and machine learning retrospective database analysis
Authors
Loading...
LncRNA signature may refine HCC prognostication; leaves open clinical adoption pending prospective validation.
Does a four-lncRNA signature predict survival in patients with hepatocellular carcinoma?
A four-lncRNA signature serves as an independent predictor of survival in patients with hepatocellular carcinoma.
Jiang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: